Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/20694
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMurphy, Declan G-
dc.contributor.authorSathianathen, Niranjan J-
dc.contributor.authorHofman, Michael S-
dc.contributor.authorAzad, Arun-
dc.contributor.authorLawrentschuk, Nathan-
dc.date2019-03-29-
dc.date.accessioned2019-04-30T23:55:26Z-
dc.date.available2019-04-30T23:55:26Z-
dc.date.issued2019-03-29-
dc.identifier.citationEuropean urology oncology 2019; 2(2): 163-165-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/20694-
dc.language.isoeng-
dc.titleWhere to Next for Theranostics in Prostate Cancer?-
dc.typeJournal Article-
dc.identifier.journaltitleEuropean urology oncology-
dc.identifier.affiliationDepartment of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationMolecular Imaging and Nuclear Medicine Therapeutics, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationDivision of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Australiaen
dc.identifier.affiliationThe Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Australiaen
dc.identifier.doi10.1016/j.euo.2019.03.004-
dc.identifier.orcid0000-0001-8553-5618-
dc.identifier.orcid0000-0002-3710-014X-
dc.identifier.pubmedid31017092-
dc.type.austinEditorial-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.languageiso639-1en-
item.cerifentitytypePublications-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

38
checked on Dec 18, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.